Generic placeholder image

Current Clinical Pharmacology

Editor-in-Chief

ISSN (Print): 1574-8847
ISSN (Online): 2212-3938

Designer Drugs on the Internet: A Phenomenon Out-of-Control? The Emergence of Hallucinogenic Drug Bromo-Dragonfly

Author(s): Liv Flesland, Norbert Scherbaum, Peer Van Der Kreeft, Cinzia Pezzolesi, Arvid Skutle, Holger Siemann, Harry Shapiro, Agnieszka Pisarska, Jacek Moskalewicz, Barbara Mervo, Ornella Corazza, Lucia Di Furia, Zsolt Demetrovics, Marta Torrens, Colin Drummond, Zoe Davey, Paolo Deluca, Magi Farre and Fabrizio Schifano

Volume 6, Issue 2, 2011

Page: [125 - 129] Pages: 5

DOI: 10.2174/157488411796151129

Price: $65

Abstract

Based on the material available in both the scientific literature and on the web, the present paper provides an updated pharmacological, chemical, toxicological and behavioural overview of Bromo-Dragonfly (1-(8-bromobenzo[1,2- b;4,5-b]difuran-4-yl)-2-aminopropane; ‘ B-fly’). B-Fly is a powerful, long lasting, LSD-like, hallucinogenic drug, which has been associated with a number of acute intoxications and fatalities in a number of countries. A critical discussion of the potential of misuse of B-fly but also of the methodological limitations, which are intrinsically associated with the analysis of online, non-peer reviewed, material, is presented. It is concluded that the availability of online information on novel psychoactive drugs, such as B-fly, may constitute a public health challenge. Better international collaboration levels may be needed to tackle this novel and fast growing phenomenon

Keywords: ABDF, Bromo-Dragonfly, FLY-compounds, internet monitoring, phenethylamines, designer drugs, ReDNet project, research chemicals, psychoactive drugs


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy